Adma Biologics | ADMA - 流动负债

金融业

USD

USD 665.18M

现金及等价物

USD 138.15M

USD 33.74M

USD 511.17M

USD 73.54M

USD 204.41M

USD 59.23M

USD 61.07M

624

EPS每股收益

USD 0.19

股本和储备

USD 390.33M

USD 80.75M

债务利息支出

USD 2.1M

USD 1.09M

USD 193.58M

USD 2.12B

USD 45.33M

USD 64.2M

USD 50.29M

普通股股本

USD 232.29M

15.02

USD 57.13M

USD 114.5M

销售和管理费用

USD 26.74M

USD 222.1M

贸易债权人

USD 20.52M

应收帐款人

USD 135.86M

	流动负债	更改		日
Adma Biologics	USD 73.54M		4M	2026-03
Alnylam Pharmaceuticals	USD 1.35B		116.87M	2026-03
BioCryst Pharmaceuticals	USD 195.39M		675K	2026-03
Minerva Neurosciences	USD 2.29M		381K	2025-12
Novavax	USD 342.46M		117.49M	2026-03
Omeros	USD 85.5M		2.28M	2025-06
Takeda	JPY 2.43T		180.65B	2026-03